GGD Rotterdam Rijnmond
Welcome,         Profile    Billing    Logout  
 4 Trials 
7 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Rijnders, Bart JA
COVIC-19, NCT05271929: Early High-Titre Convalescent Plasma in Clinically Vulnerable Individuals With Mild COVID-19

Terminated
3
120
Europe
Current standard of care and COVID-19 convalescent and vaccinated plasma, Current standard of care
Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen, NHS Blood and Transplant, Erasmus Medical Center
COVID-19
01/24
06/24
IA-DUET, NCT04876716 / 2020-000627-40: Azole-echinocandin Combination Therapy for Invasive Aspergillosis

Terminated
3
66
Europe
Azole, Voriconazole, isavuconazole, posaconazole, Anidulafungin, Ecalta
Erasmus Medical Center, ZonMw: The Netherlands Organisation for Health Research and Development, Stichting Hemato-Oncologie voor Volwassenen Nederland
Invasive Aspergillosis
05/24
05/24
FORMULA-OLS, NCT03583164 / 2017-001290-17: Evaluate F901318 (Olorofim) Treatment of Invasive Fungal Infections in Participants Lacking Treatment Options

Completed
2
203
Europe, US, RoW
Olorofim, F901318
F2G Biotech GmbH, Iqvia Pty Ltd
Invasive Fungal Infections
02/23
02/23
NCT04005248: Prevalence of HCV in HIV-negative MSM

Recruiting
N/A
4000
Europe
HCV IgG test
Erasmus Medical Center, Public Health Service of Rotterdam-Rijnmond
Hepatitis C Virus Infection
12/22
06/23
SELFIE, NCT04004299: Self-testing for HCV Re-infection in MSM

Recruiting
N/A
200
Europe
HCV RNA self-test
Erasmus Medical Center
Hepatitis C Recurrent, HIV-1-infection
02/23
06/23
ARPO, NCT06069505: Detection of Azole Resistance Inducing Mutations on DNA Extracted Directly From Serum or Plasma of Immunocompromised Patients With an Invasive Aspergillus Infection Azole Resistance PCR Optimalization-study

Recruiting
N/A
300
Europe
Aspergillus PCR
Bart Rijnders
Invasive Aspergillosis
12/30
12/30
#AwareHIV, NCT05225493: HIV Indicator Diseases in Hospital and Primary Care

Recruiting
N/A
1500
Europe
Peer to peer feedback, HIV rapid test
Erasmus Medical Center, Huisartspraktijk Gezondheidscentrum Mathenesserlaan, TU Delft department of Artificial Intelligence and MyTomorrows, Huisartsen Groep Rotterdam, AwareHIV Project Group, Huisartspraktijk Handellaan, Huisartspraktijk Leerdam, Huisartspraktijk Capelle ad IJssel, Leiden University Medical Center, Maasstadziekenhuis, Rijnstate Hospital, Medical Center Haaglanden
HIV Infections, Primary Health Care, Acquired Immunodeficiency Syndrome, Sexually Transmitted Diseases, Viral, Herpes Zoster, Dermatitis, Seborrheic, Pneumonia, Infectious Mononucleosis, Psoriasis, Candida Infection, Lymphadenopathy, Uterine Cervical Dysplasia, Weight Loss, Diarrhea Chronic, Leukopenia, Thrombocytopenia, AIDS Defining Illness, HIV Indicator Condition
05/24
05/24
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Rijnders, Bart JA
COVIC-19, NCT05271929: Early High-Titre Convalescent Plasma in Clinically Vulnerable Individuals With Mild COVID-19

Terminated
3
120
Europe
Current standard of care and COVID-19 convalescent and vaccinated plasma, Current standard of care
Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen, NHS Blood and Transplant, Erasmus Medical Center
COVID-19
01/24
06/24
IA-DUET, NCT04876716 / 2020-000627-40: Azole-echinocandin Combination Therapy for Invasive Aspergillosis

Terminated
3
66
Europe
Azole, Voriconazole, isavuconazole, posaconazole, Anidulafungin, Ecalta
Erasmus Medical Center, ZonMw: The Netherlands Organisation for Health Research and Development, Stichting Hemato-Oncologie voor Volwassenen Nederland
Invasive Aspergillosis
05/24
05/24
FORMULA-OLS, NCT03583164 / 2017-001290-17: Evaluate F901318 (Olorofim) Treatment of Invasive Fungal Infections in Participants Lacking Treatment Options

Completed
2
203
Europe, US, RoW
Olorofim, F901318
F2G Biotech GmbH, Iqvia Pty Ltd
Invasive Fungal Infections
02/23
02/23
NCT04005248: Prevalence of HCV in HIV-negative MSM

Recruiting
N/A
4000
Europe
HCV IgG test
Erasmus Medical Center, Public Health Service of Rotterdam-Rijnmond
Hepatitis C Virus Infection
12/22
06/23
SELFIE, NCT04004299: Self-testing for HCV Re-infection in MSM

Recruiting
N/A
200
Europe
HCV RNA self-test
Erasmus Medical Center
Hepatitis C Recurrent, HIV-1-infection
02/23
06/23
ARPO, NCT06069505: Detection of Azole Resistance Inducing Mutations on DNA Extracted Directly From Serum or Plasma of Immunocompromised Patients With an Invasive Aspergillus Infection Azole Resistance PCR Optimalization-study

Recruiting
N/A
300
Europe
Aspergillus PCR
Bart Rijnders
Invasive Aspergillosis
12/30
12/30
#AwareHIV, NCT05225493: HIV Indicator Diseases in Hospital and Primary Care

Recruiting
N/A
1500
Europe
Peer to peer feedback, HIV rapid test
Erasmus Medical Center, Huisartspraktijk Gezondheidscentrum Mathenesserlaan, TU Delft department of Artificial Intelligence and MyTomorrows, Huisartsen Groep Rotterdam, AwareHIV Project Group, Huisartspraktijk Handellaan, Huisartspraktijk Leerdam, Huisartspraktijk Capelle ad IJssel, Leiden University Medical Center, Maasstadziekenhuis, Rijnstate Hospital, Medical Center Haaglanden
HIV Infections, Primary Health Care, Acquired Immunodeficiency Syndrome, Sexually Transmitted Diseases, Viral, Herpes Zoster, Dermatitis, Seborrheic, Pneumonia, Infectious Mononucleosis, Psoriasis, Candida Infection, Lymphadenopathy, Uterine Cervical Dysplasia, Weight Loss, Diarrhea Chronic, Leukopenia, Thrombocytopenia, AIDS Defining Illness, HIV Indicator Condition
05/24
05/24

Download Options